After months of intense lobbying efforts, PET advocates received good news this month when the Health Care Financing Administration agreed to expand its reimbursement coverage for PET applications. According to ADAC Laboratories of Milpitas, CA, HCFA
After months of intense lobbying efforts, PET advocates received good news this month when the Health Care Financing Administration agreed to expand its reimbursement coverage for PET applications. According to ADAC Laboratories of Milpitas, CA, HCFA announced March 10 that in addition to covering cardiac and lung cancer applications (the latter including both PET and coincidence detection techniques), it will cover PET scans used to diagnose and manage three additional oncology applications: colorectal cancer, Hodgkins and non-Hodgkins lymphoma, and melanoma.
Last June, HCFA established a solid reimbursement rate of $1980 for cardiac and lung cancer imaging applications, exceeding many industry watchers expectations (SCAN 6/10/98). But PET advocates continued to negotiate with HCFA for more coverage. In January, representatives of the nuclear medicine community, including the Institute for Clinical PET of Foothill Ranch, CA, as well as practitioners, vendors, and patients, met with HCFA officials in Baltimore to discuss expanding reimbursement (SCAN 3/3/99 and 2/17/99). PET advocates argued that HCFAs clinical validation standards were too rigorous. Although some progress was made, the meeting ended inconclusively.
The agency surprised lobbyists with this months announcement, which opens the door to increased patient access to the technology.
We are particularly pleased (with HCFAs decision) because more patients will have access to this significant diagnostic tool, said Ruth Tesar, president of the ICP.
Current Perspectives on Radiology Workforce Issues and Potential Solutions
March 14th 2024Emphasizing the gravity of the ongoing workforce shortage in radiology, these authors recommend a change agenda focusing on expanded numbers of residency positions, reassessment of educational pathways, maintaining a strong presence in hospital settings and practice level initiatives to reduce administrative burden and achieve appropriate reimbursement beyond RVU measurements.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.